Phenytoin pharmacokinetics in burned rats and plasma protein binding of phenytoin in burned patients
- PMID: 7359372
Phenytoin pharmacokinetics in burned rats and plasma protein binding of phenytoin in burned patients
Abstract
Unexpectedly low serum phenytoin levels occurred in burned epileptic patients, suggesting the possibility of altered phenytoin disposition. Subsequently, phenytoin log-linear elimination kinetics after a 10 mg/kg i.v. single dose was examined in a burned rat model. Clearance increased from 1.08 +/- 0.28 liters/hr/kg in control rats to 1.50 +/- 0.38 liters/hr/kg in burned rats (P less than .05). The volume of distribution increased from 0.82 +/- 0.058 liters/kg in control rats to 1.01 +/- 0.11 liters/kg in burned rats (P less than .0005). The first order elimination rate constant (KE) did not change significantly (1.31 +/- 0.37) hr-1 in control rats vs. 1.52 +/- 0.48 hr-1 in burned rats; P greater than .05). The increase in clearance and in volume of distribution could be explained on the basis of a decrease in plasma protein binding. The free fraction in plasma increased from 27.1% +/- 1.2 in controls to 33.4% +/- 1.6 in burned rats (P less than .0005). The change in binding was consistent with a decrease in serum albumin from 2.64 +/- 0.33 g/dl in controls to 1.98 +/- 0.16 g/dl in burned rats (P less than .0005). Plasma samples of four burned human subjects revealed low serum albumin and markedly decreased plasma protein binding of phenytoin (2- to 3-fold increase in free fraction in plasma).
Similar articles
-
Plasma protein binding and metabolic clearance of phenytoin in the rat.J Pharmacol Exp Ther. 1977 Dec;203(3):500-6. J Pharmacol Exp Ther. 1977. PMID: 925955
-
Pharmacokinetics of d-tubocurarine in patients with thermal injury.Anesth Analg. 1982 Mar;61(3):241-6. Anesth Analg. 1982. PMID: 7199837
-
Effects of salicylate on maternal and fetal phenytoin pharmacokinetics in rats.Drug Metab Dispos. 1984 May-Jun;12(3):285-90. Drug Metab Dispos. 1984. PMID: 6145554
-
Plasma protein binding of phenytoin in health and disease: relevance to therapeutic drug monitoring.Ther Drug Monit. 1980;2(4):331-44. Ther Drug Monit. 1980. PMID: 7013166 Review.
-
Burns and epilepsy--review and case report.Burns. 2015 Mar;41(2):e15-8. doi: 10.1016/j.burns.2014.08.004. Epub 2014 Oct 23. Burns. 2015. PMID: 25440855 Review.
Cited by
-
Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients.Clin Pharmacokinet. 2008;47(10):635-54. doi: 10.2165/00003088-200847100-00002. Clin Pharmacokinet. 2008. PMID: 18783295 Review.
-
Therapeutic drug monitoring in pregnancy: rationale and current status.Clin Pharmacokinet. 1990 Dec;19(6):425-33. doi: 10.2165/00003088-199019060-00002. Clin Pharmacokinet. 1990. PMID: 2292167 Review. No abstract available.
-
Clinical pharmacological and therapeutic considerations in general intensive care. A review.Drugs. 1987 Dec;34(6):662-94. doi: 10.2165/00003495-198734060-00003. Drugs. 1987. PMID: 3322782 Free PMC article. Review.
-
Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).Clin Pharmacokinet. 1990 Sep;19(3):218-29. doi: 10.2165/00003088-199019030-00005. Clin Pharmacokinet. 1990. PMID: 2203581 Review.
-
Clinical pharmacokinetics in patients with burns.Clin Pharmacokinet. 1995 Jul;29(1):15-28. doi: 10.2165/00003088-199529010-00003. Clin Pharmacokinet. 1995. PMID: 7586895 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical